Navigation Links
New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ
Date:9/19/2007

PARSIPPANY, N.J., Sept. 19 /PRNewswire/ -- Over 20 new speakers will grace the faculty of the "Pharma & Biotech Competitive Intelligence & Business Analysis" conference in two weeks in New Jersey. The conference is the gold standard for pharmaceutical CI, Business Analysis, and Market Forecasting executives; 200 from the top 25 companies will gather on October 1-2 to attend the meeting. Competition has never been fiercer to launch successful products and monitor competitor moves in crowded therapeutic classes. This year's show brings together an unprecedented gathering of speakers and attendees from around the industry.

Among the many new speakers the audience will have opportunity to hear from are:

-- Bill Sammon

Senior Director of Strategy Information Analysis

Pfizer

-- David Stefanoni

Director, Business Intelligence; Business Excellent, Analytics &

Planning

Sanofi-Aventis

-- David Kamenir

Associate Director, Strategic Brand & Competitor Insights

Novo Nordisk

-- Ian Malcolm

Vice President Strategic Marketing

Exelixis

-- Susanne Laningham

Director Business Analysis & Information

Amgen

-- Thomas Han

Director, Strategic Marketing

Biovail

-- J J Owen

Associate Director, Scientific & Competitor Analysis

Millennium

-- Joshua Owolabi

Assistant Director, Discovery & Assessment Group

TAP Pharmaceuticals

-- Renee Pierson

Director

Ortho McNeil Pharmaceutical

The conference and exhibition will take place in Parsippany, NJ and is the only annual conference featuring 90% pharmaceutical company speakers for just the life sciences industry, reports Mark Alexay of Apaporis, the organizer. 35 pharmaceutical company speakers are featured this year; the attendee list is posted at http://www.pharmabiotechci.com.

The speaking faculty includes a pharmaceutical industry "Who's Who" list of CI professionals from top companies including Alcon Laboratories, Amgen, Aspreva, Bayer HealthCare, Bayer Schering Pharma, Biovail, Boehringer Ingelheim, Centocor, Cyberonics, Cyclacel, Daiichi Medical Research, Eisai, Exelixis, Genentech, Genzyme, Merck, Millennium, Novo Nordisk, Onconova Therapeutics, Organon International, Ortho McNeil Pharmaceutical, Pfizer, Sanofi-Aventis, Shire Laboratories, Supernus Pharmaceuticals, TAP, Wyeth, ZymoGenetics.

Contact the organizers for information or about the exhibition -- Amy Yueh at ayueh@pharmabiotechci.com / 212.228.7974 or Mark Alexay at 201.452.4023.


'/>"/>
SOURCE Apaporis
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. In competitive biotech world, Wisconsin cant afford to fall behind
2. Modernizing the tax code can make Wisconsin tech businesses more competitive
3. Is Googles cafeteria a competitive weapon?
4. Wisconsin can shine in the competitive biotech world, even among the giants
5. Wisconsin must produce more science-savvy students to remain competitive
6. Is your competitive edge really a wedge?
7. Schneider Logistics Helps Manufacturers Secure Competitive Advantage
8. Looking to be Competitive? Try Speed Networking
9. Meat-snack maker selects Prescient Applied Intelligence tech package
10. Are you gathering information or intelligence about competitors?
11. Business Intelligence and Process Effectiveness Processes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):